PTX3 and chronic obstructive pulmonary disease: Pentraxin-3 (PTX-3), an acute-phase protein, has emerged as a promising candidate due to its role in the innate immune response and inflammation, both of which are pivotal in COPD pathogenesis and exacerbations [12, 13].